A Toronto-based company is developing a highly versatile point-of-care (POC) diagnostic platform which will enable unparalleled sample-to-action workflow in the clinic. Utilizing a patented approach for analyte detection, the platform can perform multiple classes of assays including cell surface markers, proteins and nucleic acids from an easily collected sample. We seek a highly skilled, entrepreneurial CEO to lead our early stage diagnostic platform company. You will direct and oversee fundraising, corporate development and all operations of the company.
You must be a visionary director who is passionate about bringing innovative diagnostic platforms to market while leading it to financial success. He/She will lead the strategic planning for commercialization and fundraising, establish additional partnerships for broader POC applications and lead the company to a successful outcome for investors.